18 /100
LOW RISK
Score updated May 28, 2026

REGN — Regeneron Pharmaceuticals, Inc. Dilution Risk Tracker

Track REGN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track REGN — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
5
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
7%
📉 Score Deterioration 15%
• Score climbed 8 points (worsening)
🔔 Track REGN — Get forecast alerts →

💹 Market Data

Market Cap$65.40B
Shares Outstanding103.02M
Float97.67M
Cash$8.75B
Debt$3.49B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 4.0% shares (2025Q4 vs prior)
1379 institutional holders · 95.63M shares
#1 VANGUARD GROUP INC 9.08M shares
#2 BlackRock, Inc. 8.74M shares
#3 STATE STREET CORP 4.66M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest3.27M
Days to Cover4.1
% of Float3.4%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2016
xbrl XBRL WARRANT Dec 31, 2014
4 INSIDER TRANSACTION Apr 03, 2026
4 INSIDER TRANSACTION Mar 03, 2026
4 INSIDER TRANSACTION Feb 11, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track REGN Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking REGN — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for REGN
📊 REGN FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 REGN Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.